Krane Funds Advisors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-39,357
Closed -$349K 117
2022
Q3
$349K Sell
39,357
-1,201
-3% -$15.1K 0.02% 103
2022
Q2
$513K Sell
40,558
-3,677
-8% -$46.8K 0.02% 76
2022
Q1
$837K Buy
44,235
+3,275
+8% +$83.4K 0.03% 83
2021
Q4
$1.44M Sell
40,960
-10,468
-20% -$340K 0.04% 62
2021
Q3
$1.88M Buy
51,428
+4,990
+11% +$196K 0.04% 59
2021
Q2
$1.82M Sell
46,438
-1,635
-3% -$47.2K 0.05% 56
2021
Q1
$1.36M Buy
48,073
+14,302
+42% +$456K 0.05% 67
2020
Q4
$1.08M Buy
33,771
+2,394
+8% +$73.6K 0.04% 60
2020
Q3
$1.01M Buy
31,377
+11,834
+61% +$369K 0.05% 39
2020
Q2
$539K Buy
19,543
+8,103
+71% +$176K 0.03% 84
2020
Q1
$204K Buy
11,440
+2,727
+31% +$65.8K 0.01% 201
2019
Q4
$218K Buy
8,713
+1,895
+28% +$41.5K 0.01% 207
2019
Q3
$122K Sell
6,818
-2,174
-24% -$45.3K 0.01% 208
2019
Q2
$198K Sell
8,992
-9,422
-51% -$269K 0.02% 58
2019
Q1
$563K Buy
18,414
+1,109
+6% +$27.7K 0.03% 61
2018
Q4
$400 Buy
+17,305
New +$538K 0.02% 67

Other funds holding HCM

Krane Funds Advisors's HCM Position: Q4 2022 in Review

Krane Funds Advisors sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 39,357 shares — an estimated $349K sold.

Krane Funds Advisors first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $1.88M in Q3 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Krane Funds Advisors reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Krane Funds Advisors sold 39,357 HUTCHMED shares in Q4 2022, an estimated $349K.
  • Krane Funds Advisors first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
  • Krane Funds Advisors's HUTCHMED position peaked at $1.88M in Q3 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Krane Funds Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.